Claudio Corallo
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis.
Journal: Scientific reports
Published: April 08, 2022
Association between microvascular and macrovascular damage in patients with systemic sclerosis: an upper limb echo-color-doppler and nailfold videocapillaroscopy study.
Journal: Journal of biological regulators and homeostatic agents
Published: January 08, 2020
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study.
Journal: Rheumatology (Oxford, England)
Published: December 19, 2019
Erratum to "Methylsulfonylmethane and mobilee prevent negative effect of IL-1β in human chondrocyte cultures via NF-κB signaling pathway" [Int. Immunopharmacol. 65 (2018) 129-139].
Journal: International immunopharmacology
Published: July 31, 2019
MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes.
Journal: Cells
Published: July 03, 2019
Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.
Journal: Rheumatology international
Published: June 04, 2019
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
Journal: Arthritis research & therapy
Published: March 18, 2019
Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
Journal: Clinical and experimental rheumatology
Published: January 12, 2019
Methylsulfonylmethane and mobilee prevent negative effect of IL-1β in human chondrocyte cultures via NF-κB signaling pathway.
Journal: International immunopharmacology
Published: August 03, 2018
Pulmonary arterial hypertension in systemic sclerosis: Diagnosis and treatment according to the European Society of Cardiology and European Respiratory Society 2015 guidelines.
Journal: Journal of scleroderma and related disorders
Published: July 07, 2018
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
Journal: Arthritis research & therapy
Published: January 05, 2018
Last Updated: 09/26/2026